DeutschNewstral
Article
Mmarketwatch.com on 2019-08-13 14:46
Deciphera Pharmaceuticals stock more than doubles on heavy volume after positive trial data
Related news
- MOncoCyte's stock doubles on heavy volume after positive results of cancer detection testmarketwatch.com
- MProgenics Pharmaceuticals stock soars 29% on news of positive results in prostate cancer drug trialmarketwatch.com
- MMerrimack Pharmaceuticals' stock soars on heavy volume after drug sale dealmarketwatch.com
- MAslan Pharmaceuticals' stock soars on heavy volume, after rocketing nearly 9-fold the past weekmarketwatch.com
- MAkari Therapeutics' stock rockets on heavy volume after FDA grants nomacopan 'Fast Track' designationmarketwatch.com
- MMelinta Therapeutics' stock rockets on heavy volume after FDA accepts sNDA for Baxdelamarketwatch.com
- MEDAP's stock rockets on heavy volume after prostate treatment gets FDA marketing clearancemarketwatch.com
- MDPW's stock more than doubles on heavy volume after announcing defense ordersmarketwatch.com
- MDPW's stock more than doubles on heavy volume after Coolisys business introduces new EV chargesmarketwatch.com
- MAEterna Zentaris's stock more than doubles on heavy volume after favorable FDA rulingmarketwatch.com
- MTaronis' stock doubles on heavy volume after contract signed with a potential value of $165 millionmarketwatch.com
- MPortola's stock more than doubles on heavy volume after Alexion buyout dealmarketwatch.com
- MAltimmune's stock soars on heavy volume after positive trial data of flu vaccine candidatemarketwatch.com
- MMirati Therapeutics' stock soars on heavy volume after positive cancer treatment trial resultsmarketwatch.com
- MAxsome's stock nearly triples on heavy volume after positive trial of depression treatmentmarketwatch.com
- MEli Lilly's stock surges on heavy volume after positive drug test resultsmarketwatch.com
- MLendingClub's stock extends plunge on heavy volumemarketwatch.com
- MFitbit's stock soars on heavy volume, againmarketwatch.com
- MAchillion Pharmaceuticals' stock rockets after Alexion Pharmaceuticals $930 million buyout dealmarketwatch.com
- MPetrobras stock falls on heavy volume after public stock offeringmarketwatch.com